Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?

doi:10.4254/wjh.v13.i2.233

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5838)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

300

WORD

201

HTML

2403

Figures (1-4)

277

Tables (1-1)

274

Sum=3455

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

360

Download

513

Sum=873

Publishing Process of This Article

Item

Count

Browse

496

Download

1014

Sum=1510

Feb 27, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine

World J Hepatol. Feb 27, 2021; 13(2): 233-241
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.233

Full Size Figure Download Figure

Figure 4 The non-alcoholic steatohepatitis patient recruitment screening pathway. LFT: Liver function test; FBC: Full blood count; INR: International normalized ratio; PT: Prothrobmin time; PTT: Partial thromboplastin time; CAP: Controlled attenuation parameter; PCV: Porcine circovirus; NAFLD: Non-alcoholic fatty liver disease; FIB: Fibrosis.

Citation: Wessels DH, Rosenberg Z. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? World J Hepatol 2021; 13(2): 233-241
URL: https://www.wjgnet.com/1948-5182/full/v13/i2/233.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i2.233